We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£520.00
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 3 months
Chemotherapy and Antibody Therapy Outlook 2023-2028 Report
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 84 days · 84 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 84 days • 1 price levels
Price Analysis
Most common price: £520 (84 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 84 days
Description
Key Features
Provides latent demand estimates in millions of U.S. dollars for chemotherapy and antibody combination therapies.
Includes detailed data coverage for approximately 12,600 cities across the United States.
Offers potential industry earnings (P.I.E.) estimates to assist with market analysis.
Reports the percent share of each city compared to its state and the total U.S. market.
Provides comparative benchmarks to help gauge city performance against others.
Supports distribution and sales force strategy through detailed statistical insights.
Product Specifications
- Format
- paperback
- ASIN
- B0BLQLR9LF
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
Chemotherapy and Antibody Therapy Outlook in India 2023-2028
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
Cancer Supportive Care Drugs Outlook 2023-2028 Report
India Cancer Supportive Care Drugs Outlook 2023-2028
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
World Outlook for Immune-Oncology Treatments 2025-2030
2025-2030 World Outlook for Immuno Oncology Assays Report
US Cancer Supportive Care Outlook 2023-2028 Study Report
The 2023 Report on Non-Hodgkin Lymphoma Chemotherapy Therapeutics: World Market Segmentation by City
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2021-2026 World Outlook for Silent Cancer Therapeutics
The 2023-2028 Outlook for Cancer Vaccines in India
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Cancer Vaccines in the United States
Cancer Therapy Outlook 2016-2021 - North America & Caribbean
